This phase II trial tests the safety and side effects of adding melphalan (by injecting it into the eye) to standard chemotherapy in early treatment of patient…

Bilateral RetinoblastomaChildhood Intraocular RetinoblastomaGroup D Retinoblastoma+2 more

~Estimated

~$10 – $7,500

Children's Oncology GroupNCT05504291

Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)

This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members thr…

RetinoblastomaCancer SurvivorBiological Sibling+2 more

~Estimated

~$10 – $750

Vanderbilt-Ingram Cancer CenterNCT03932786